News

Australia’s health regulator is bringing in some major changes, in an effort to make things safer for patients and more raise training standards.
New rules for injectables target quick telehealth consults, the role of influencers and nurse training, in an attempt to ...
Introduction: The global botulinum toxin market has evolved from being a beauty-industry phenomenon to becoming a ...
A newer trend in Botox and fillers is gaining popularity for its dual benefits, addressing both cosmetic concerns and medical conditions.
For the first time, I could walk into a room or hold someone’s gaze without bracing for that quiet voice in the back of my mind. I didn’t go into that appointment looking for transformation. I ...
CINCINNATI (WXIX) - Migraines affect an estimated 37 million adults in the U.S. and some are turning to Botox to find relief. Migraine symptoms often start with throbbing head pain and can include ...
Our approach integrates cutting-edge scalable human models, state-of-the-art technology and proprietary engineering, and learning and surrogate AI/ML models to identify novel therapeutic targets ...
By utilizing this pathway, we plan to bring ABP-450 to the U.S. market under a single FDA approval that could cover all of BOTOX’s currently approved and future therapeutic indications,” commented Rob ...
By utilizing this pathway, we plan to bring ABP-450 to the U.S. market under a single FDA approval that could cover all of BOTOX’s currently approved and future therapeutic indications ...
ABP-450 is a biosimilar botulinum toxin complex for various therapeutic indications, aiming to provide a cost-effective alternative to BOTOX. What regulatory pathway is AEON pursuing for ABP-450?